Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-07-006985
Filing Date
2007-05-08
Accepted
2007-05-08 15:37:15
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y34632e10vq.htm 10-Q 305346
2 EX-10.3: AMENDED AND RESTATED LICENSE AGREEMENT, DATED APRIL 20, 2007 y34632exv10w3.htm EX-10.3 223951
3 EX-31.1: CERTIFICATION y34632exv31w1.htm EX-31.1 6761
4 EX-31.2: CERTIFICATION y34632exv31w2.htm EX-31.2 6710
5 EX-32.1: CERTIFICATION y34632exv32w1.htm EX-32.1 2880
6 EX-32.2: CERTIFICATION y34632exv32w2.htm EX-32.2 2927
  Complete submission text file 0000950123-07-006985.txt   550063
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 07828036
SIC: 2835 In Vitro & In Vivo Diagnostic Substances